Rajeev M. Shah, Director at Cytek Biosciences, Inc. (CTKB), bought 1,094,760 shares at $14.12 ($15.4M) on 2022-02-18, disclosed to the SEC on 2022-02-22.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $14.78 | 166,229 | $2.5M | 16.0% |
| 2 | $14.78 | 166,229 | $2.5M | 16.0% |
| 3 | $14.12 | 166,229 | $2.3M | 15.2% |
| 4 | $14.12 | 166,229 | $2.3M | 15.2% |
| 5 | $13.46 | 214,922 | $2.9M | 18.8% |
| 6 | $13.46 | 214,922 |
| $2.9M |
| 18.8% |
| Total | $14.06 avg | 1,094,760 | $15.4M | 100% |
| Filing → |
| SEPN | BUY | 2024-10-30 | $75.1M | — | Filing → |
| AVTE | BUY | 2024-06-20 | $3.1M | — | Filing → |
| HOWL | BUY | 2023-01-10 | $4.1M | — | Filing → |